WallStreetZenWallStreetZen

NASDAQ: RVPH
Reviva Pharmaceuticals Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RVPH

Based on 3 analysts offering 12 month price targets for Reviva Pharmaceuticals Holdings Inc.
Min Forecast
$12.00+297.35%
Avg Forecast
$16.33+440.83%
Max Forecast
$20.00+562.25%

Should I buy or sell RVPH stock?

Based on 3 analysts offering ratings for Reviva Pharmaceuticals Holdings Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RVPH stock forecasts and price targets.

RVPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2024-03-25
lockedlocked$00.00+00.00%2023-10-30

1 of 1

Forecast return on equity

Is RVPH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is RVPH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RVPH revenue forecast

What is RVPH's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$67.4M
Avg 2 year Forecast
$185.9M
Avg 3 year Forecast
$319.8M

RVPH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RVPH$3.02$16.33+440.83%Strong Buy
CRIS$14.31$26.00+81.69%Strong Buy
BTAI$2.75$7.25+163.64%Strong Buy
MCRB$0.56$4.75+748.21%Hold
PLX$1.15$10.00+769.57%Buy
View Top Biotech Stocks

Reviva Pharmaceuticals Holdings Stock Forecast FAQ

Is Reviva Pharmaceuticals Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: RVPH) stock is to Strong Buy RVPH stock.

Out of 3 analysts, 1 (33.33%) are recommending RVPH as a Strong Buy, 2 (66.67%) are recommending RVPH as a Buy, 0 (0%) are recommending RVPH as a Hold, 0 (0%) are recommending RVPH as a Sell, and 0 (0%) are recommending RVPH as a Strong Sell.

If you're new to stock investing, here's how to buy Reviva Pharmaceuticals Holdings stock.

What is RVPH's revenue growth forecast for 2027-2029?

(NASDAQ: RVPH) Reviva Pharmaceuticals Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Reviva Pharmaceuticals Holdings's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast RVPH's revenue for 2027 to be $1,882,827,686, with the lowest RVPH revenue forecast at $1,882,827,686, and the highest RVPH revenue forecast at $1,882,827,686. On average, 1 Wall Street analysts forecast RVPH's revenue for 2028 to be $5,188,943,562, with the lowest RVPH revenue forecast at $5,188,943,562, and the highest RVPH revenue forecast at $5,188,943,562.

In 2029, RVPH is forecast to generate $8,927,238,746 in revenue, with the lowest revenue forecast at $8,927,238,746 and the highest revenue forecast at $8,927,238,746.

What is RVPH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RVPH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RVPH's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RVPH price target, the average RVPH price target is $16.33, with the highest RVPH stock price forecast at $20.00 and the lowest RVPH stock price forecast at $12.00.

On average, Wall Street analysts predict that Reviva Pharmaceuticals Holdings's share price could reach $16.33 by Apr 16, 2025. The average Reviva Pharmaceuticals Holdings stock price prediction forecasts a potential upside of 440.83% from the current RVPH share price of $3.02.

What is RVPH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RVPH) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.